CompletedPhase 2NCT00234663

PTC124 for Cystic Fibrosis

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
PTC Therapeutics
Principal Investigator
John P Clancy, MD
University of Alabama at Birmingham
Intervention
PTC124(drug)
Enrollment
24 enrolled
Eligibility
18 years · All sexes
Timeline
20052006

Study locations (5)

Collaborators

Cystic Fibrosis Foundation · FDA Office of Orphan Products Development

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00234663 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials